Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Kluft

Showing results (61-70 of 291) with videos related to

Pageof 30
Sort By:
European Journal of Biochemistry|April 15, 1986
Purification and characterization of a novel, oligomeric, plasminogen kringle 4 binding protein from human plasma: tetranectinI Clemmensen, L C Petersen, C Kluft
Maturitas|March 10, 2009
Cardiovascular risk markers during treatment with estradiol and trimegestone or dydrogesteroneM Hellgren, J Conard, L Norris, et al.
Nederlands Tijdschrift Voor Geneeskunde|January 23, 1988
[Congenital deficiency of the fibrinolysis inhibitor alpha 2-antiplasmin as a cause of hemorrhagic diathesis]F W Leebeek, E A Knot, C Kluft
Thrombosis and Haemostasis|July 29, 1984
Evidence for the occurrence of a fast-acting inhibitor for tissue-type plasminogen activator in human plasmaJ H Verheijen, G T Chang, C Kluft
International Journal of Laboratory Hematology|November 16, 2012
Preincubation in the Prothrombinase-induced Clotting Time test (PiCT) is necessary for in vitro evaluation of fondaparinux and to be avoided for the reversible, direct factor Xa inhibitor, rivaroxabanC Kluft, P Meijer, R Kret, et al.
Arteriosclerosis (Dallas, Tex.)|September 1, 1985
Effect of chronic smoking on fibrinolysisR A Allen, C Kluft, E J Brommer
Agents and Actions. Supplements|January 1, 1992
Variable depletion of endogenous factor XII-dependent fibrinolytic activity following thrombolytic therapy of myocardial infarction and its relation to reinfarctionC Kluft, S Munkvad, J Gram, et al.
European Journal of Clinical Investigation|October 1, 1984
Acute effect of smoking on fibrinolysis: increase in the activity level of circulating extrinsic (tissue-type) plasminogen activatorR A Allen, C Kluft, E J Brommer
Thrombosis Research|July 1, 1981
Blood sampling techniques for fibrinolytic studies: comparison of Vacutainer R and traditional techniquesR A Allen, E J Brommer, C Kluft
Lancet (London, England)|June 8, 1999
Acquired activated protein-C resistanceC Kluft, P Meijer, J Gram, et al.
Pageof 30

Showing results (61-70 of 291) with videos related to

Sort By:
Pageof 30
European Journal of Biochemistry|April 15, 1986
Purification and characterization of a novel, oligomeric, plasminogen kringle 4 binding protein from human plasma: tetranectinI Clemmensen, L C Petersen, C Kluft
Maturitas|March 10, 2009
Cardiovascular risk markers during treatment with estradiol and trimegestone or dydrogesteroneM Hellgren, J Conard, L Norris, et al.
Nederlands Tijdschrift Voor Geneeskunde|January 23, 1988
[Congenital deficiency of the fibrinolysis inhibitor alpha 2-antiplasmin as a cause of hemorrhagic diathesis]F W Leebeek, E A Knot, C Kluft
Thrombosis and Haemostasis|July 29, 1984
Evidence for the occurrence of a fast-acting inhibitor for tissue-type plasminogen activator in human plasmaJ H Verheijen, G T Chang, C Kluft
International Journal of Laboratory Hematology|November 16, 2012
Preincubation in the Prothrombinase-induced Clotting Time test (PiCT) is necessary for in vitro evaluation of fondaparinux and to be avoided for the reversible, direct factor Xa inhibitor, rivaroxabanC Kluft, P Meijer, R Kret, et al.
Arteriosclerosis (Dallas, Tex.)|September 1, 1985
Effect of chronic smoking on fibrinolysisR A Allen, C Kluft, E J Brommer
Agents and Actions. Supplements|January 1, 1992
Variable depletion of endogenous factor XII-dependent fibrinolytic activity following thrombolytic therapy of myocardial infarction and its relation to reinfarctionC Kluft, S Munkvad, J Gram, et al.
European Journal of Clinical Investigation|October 1, 1984
Acute effect of smoking on fibrinolysis: increase in the activity level of circulating extrinsic (tissue-type) plasminogen activatorR A Allen, C Kluft, E J Brommer
Thrombosis Research|July 1, 1981
Blood sampling techniques for fibrinolytic studies: comparison of Vacutainer R and traditional techniquesR A Allen, E J Brommer, C Kluft
Lancet (London, England)|June 8, 1999
Acquired activated protein-C resistanceC Kluft, P Meijer, J Gram, et al.
Pageof 30